| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
SVP of Corp Affairs &Admin. | SVP of Corp Affairs &Admin.
1 company
Cavanaugh Sarah is a SVP of Corp Affairs &Admin. at CLDX. Recent filings cover 1 purchase and 7 sales. Those positions are worth an estimated $17K at current prices.
Our model assigns Cavanaugh Sarah a middling insider score of 66/100, based on 5 past trades. Over a 12-month horizon, 100.0% of those trades were profitable, with an average 12-month return of +18.8%.
Cavanaugh Sarah's largest disclosed position is in CLDX as SVP of Corp Affairs &Admin., worth about $17K. The recent filings there lean toward selling, a net 67,116 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 30, 2024 | CLDX Celldex Therapeutics, Inc. | SVP of Corp Affairs &Admin. | Sale+OE | 20,853 | $33.73 | $703,334.15 | -91.8% | +14.4% | -41.2% | |
| Aug 18, 2022 | CLDX Celldex Therapeutics, Inc. | SVP of Corp Affairs &Admin. | Sale+OE | 32,667 | $36.72 | $1,199,510.34 | -96.2% | +0.7% | -11.7% | |
| Dec 8, 2021 | CLDX Celldex Therapeutics, Inc. | SVP of Corp Affairs &Admin. | Sale+OE | 7,323 | $40.00 | $292,920.00 | -94.7% | -28.0% | -2.3% | |
| Nov 1, 2021 | CLDX Celldex Therapeutics, Inc. | SVP of Corp Affairs &Admin. | Sale+OE | 7,323 | $43.26 | $316,804.37 | -94.7% | -29.7% | -19.8% | |
| Jun 10, 2020 | CLDX Celldex Therapeutics, Inc. | SVP of Corp Affairs &Admin. | Buy | 1,050 | $4.83 | $5,071.50 | +331.2% | - | - |